I'm looking for a dramatic and explosive increase in VYST's valuation metrics occurring over the next several weeks now that we're fast approaching the Rotmans Super 8k finish line, which finally officially completes VYST's long awaited RxAir, FEC & Vytex commercialization era financial foundation.
Rotmans provides VYST with a dramatic increase in leverage & resources to assist them in convincing potential big fish partners from transitioning from extensive final stage trials & testing to commercial scale deals, which could come in the form of jv's, licensing agreements, royalties or full scale product(s) rollout on the shelves and/or floor spaces of mainstream retailers.
It's 1 thing to have novel, eco-friendly & cost-effective products. But it's another thing entirely to have the financial foundation necessary and required to convince big fish commercialization partners that not only do you have the competitive advantage product(s), you have the entire across the board infrastructure and logistics to fulfill the demands of big fish partnerships. And I've touched on what all those areas of concern are about in many prior/earlier posts. Everything from having the appropriate manufacturers, distribution and warehousing, to providing appropriate advertising/branding budgeting support. The classic it takes money to make money adage most definitely applies over & above having a competitive advantage stable of products.
And since VYST has basically been operating since the end of July under the guise and premise of already having the Rotmans increased value on their books despite the Super 8k not yet being officially filed quite yet. There's a very good chance that VYST mgmt. could have multiple commercial scale deals lined up over the near term horizon now, that will immediately propel VYST up through their next seriously impactful cycles of growth far over & above the explosive valuation increase Rotmans immediately provides. And it's only gonna take an initial handful or half dozen significant Vytex commercialization era deals to put this stock on a rapid northbound trajectory from the QB to the QX when CEO Rotman finally does flip the long awaited commercialization era ignition switch directly ahead.
The Dollarland and NAZ projections will both become self-fulfilling prophecies when ALL the approaching fresh valuation driving catalysts get unleashed onto VYST's books. And since PubCo's can apply to up list onto the QX with as low as a .25 cent minimum bid provided they meet all the other QX minimum listing threshold standards, VYST could certainly be preparing to enter a shock & awe era of expectations over these next several weeks now that all their behind the scenes stars finally appear ready to align.
And if there is in fact a dramatic increase in VYST's per annum revenue run rate to north of +$100M, and VYST is in fact preparing to secure an investment banking dance partner along with figuring out how best to significantly reduce their O/S. Then everything inVYSTors ever hoped for this stock way back in February will finally start occurring this fall and far far beyond, and this stock will in fact attract the much higher breeds of investors and boutique firms I've always firmly believed will accumulate positions here for the long term massive growth ahead, as VYST proves capable of launching true sector disruptive products with big fish commercialization partners, and become a multi-BILLION-dollar giant over the next several years glty!
Market Data 
Markets 
